TWD 498.0
(3.11%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 27.26 Billion TWD | 77.85% |
2022 | 15.33 Billion TWD | 147.37% |
2021 | 6.19 Billion TWD | 12.06% |
2020 | 5.53 Billion TWD | 86.9% |
2019 | 2.95 Billion TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 27.23 Billion TWD | -0.13% |
2024 Q2 | 28.19 Billion TWD | 3.53% |
2023 Q3 | 26.88 Billion TWD | -2.64% |
2023 FY | 27.26 Billion TWD | 77.85% |
2023 Q1 | 16.57 Billion TWD | 8.08% |
2023 Q2 | 27.61 Billion TWD | 66.61% |
2023 Q4 | 27.26 Billion TWD | 1.45% |
2022 Q3 | 7.42 Billion TWD | 0.0% |
2022 Q4 | 15.33 Billion TWD | 106.49% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Grape King Bio Ltd | 15.51 Billion TWD | -75.797% |
Standard Chem & Pharm CO., LTD. | 11.18 Billion TWD | -143.721% |
Maywufa Company Ltd. | 2.83 Billion TWD | -862.875% |
ScinoPharm Taiwan, Ltd. | 11.72 Billion TWD | -132.642% |
Lotus Pharmaceutical Co., Ltd. | 32.99 Billion TWD | 17.345% |
LIWANLI Innovation Co., Ltd. | 834.17 Million TWD | -3169.024% |
YungShin Global Holding Corporation | 11.51 Billion TWD | -136.868% |
PhytoHealth Corporation | 2.35 Billion TWD | -1060.144% |
SCI Pharmtech, Inc. | 6.69 Billion TWD | -307.568% |
Formosa Laboratories, Inc. | 13.63 Billion TWD | -99.978% |
Bora Pharmaceuticals Co., LTD. | 25.05 Billion TWD | -8.851% |